Indegene quarterly results and financials

Indegene (INDGN)₹614.60−1.23%(9 Nov 2026 close)Healthcare Research, Analytics & Technology

Key facts

In the Sep 2026 quarter (consolidated), Indegene reported sales of ₹1,124 Cr, up 39.7% from Sep 2025, and net profit of ₹112 Cr, up 9.9% year on year. For the year to Mar 2026, sales were ₹3,518 Cr and net profit ₹400 Cr.

Sales (Sep 2026): ₹1,124 Cr
Net profit (Sep 2026): ₹112 Cr
Sales (FY Mar 2026): ₹3,518 Cr
Net profit (FY Mar 2026): ₹400 Cr
EPS (Sep 2026): ₹4.68
Borrowings (Mar 2026): ₹144 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Indegene quarterly results

₹ crore unless stated; each column is a quarter.

Indegene Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	675	675	677	688	721	758	762	805	943	1,005	1,065	1,124
Expenses	523	533	547	560	588	607	605	663	782	839	887	936
Operating Profit	149	139	129	126	132	148	155	141	160	164	174	186
OPM %	22.1%	21.1%	19.1%	18.1%	18.1%	20.1%	20.0%	17.1%	17.1%	16.1%	16.1%	17.1%
Other Income	13.04	26.08	22.06	21.05	38.11	26.05	22.06	20.05	19.04	−10.03	29.09	15.03
Interest	11.95	11.95	11.95	3.99	2.99	2.99	3.99	3.98	4.98	6.97	5.98	6.98
Depreciation	17.96	17.97	19.95	18.94	19.94	20.94	21.94	22.96	39.91	41.89	43.87	45.90
Profit before tax	132	134	120	124	146	149	151	133	135	105	152	147
Tax %	25.0%	29.1%	27.0%	26.0%	25.0%	21.0%	23.0%	23.0%	24.0%	24.0%	24.0%	24.0%
Exceptional items	0.00	1.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−14.96	0.00	0.00
Net Profit	98.81	94.80	87.91	91.78	110	118	116	102	103	79.86	116	112
EPS (Rs)	4.46	4.28	3.68	3.84	4.59	4.92	4.86	4.26	4.29	3.32	4.83	4.68

Indegene profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Indegene Profit and loss
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	554	644	967	1,668	2,311	2,596	2,845	3,518	4,138
Expenses	510	499	735	1,375	1,907	2,080	2,287	2,887	3,443
Operating Profit	41.93	144	230	287	396	504	547	619	684
OPM %	8.1%	22.1%	24.1%	17.1%	17.1%	20.1%	19.1%	18.1%	16.5%
Other Income	7.02	−102	−3.01	−21.05	58.17	79.24	94.20	52.17	53.13
Interest	5.98	8.97	6.97	5.98	30.87	48.82	21.92	18.93	24.91
Depreciation	16.97	18.96	25.94	32.90	59.89	75.87	79.76	126	172
Profit before tax	25.92	13.96	195	225	362	457	537	523	538
Tax %	45.0%	191.0%	23.1%	28.0%	27.0%	27.1%	25.0%	24.0%	—
Exceptional items	0.00	59.83	1.99	−26.92	0.00	1.99	−9.97	−12.96	−14.96
Net Profit	13.98	−11.97	149	163	265	336	406	400	410
EPS (Rs)	0.72	−0.33	7.57	7.46	12.03	15.20	17.01	16.69	17.12
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	12.0%	13.0%	—

Indegene balance sheet

₹ crore, at each year end.

Indegene Balance sheet
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.30	0.30	0.30	0.34	43.91	43.89	47.86	47.89
Reserves	72.88	−105	324	762	1,018	1,382	2,564	3,088
Borrowings	147	484	51.14	66.25	503	491	102	144
Other Liabilities	108	221	220	525	635	627	610	1,336
Total Liabilities	329	600	596	1,352	2,201	2,544	3,323	4,616
Fixed Assets	104	119	85.98	138	663	645	677	1,812
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	4.01	12.02
Investments	0.00	12.97	0.00	120	612	794	1,288	1,097
Other Assets	225	468	510	1,096	926	1,103	1,355	1,696
Trade receivables	90.18	224	286	445	643	649	753	983
Cash & equivalents	36.99	180	140	517	86.07	191	375	382
Total Assets	329	600	596	1,352	2,201	2,544	3,323	4,616

Indegene cash flow

₹ crore, for each year.

Indegene Cash flow
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	64.98	22.01	172	297	130	508	442	651
Cash from investing activity	−17.95	−15.97	−80.84	−158	−894	−325	−675	−506
Cash from financing activity	−20.96	136	−132	233	332	−65.88	288	−82.88
Net cash flow	24.99	143	−40.02	373	−433	115	52.06	60.01
Capex	16.96	5.99	20.94	24.95	18.97	10.97	29.95	43.93
Free cash flow	47.95	15.98	151	272	111	497	412	605
CFO / OP %	196.0%	33.9%	96.0%	127.9%	59.9%	125.0%	109.9%	128.9%

Indegene ratios

Working-capital days and returns, by year.

Indegene Ratios
	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	60	127	108	97	102	91	97	102
Cash conversion cycle	60	127	108	97	102	91	97	102
Working capital days	−6	−4	46	12	42	28	40	6
ROCE %	—	36.9%	54.9%	45.9%	33.0%	29.0%	24.9%	18.9%

Indegene: frequently asked questions

What are the latest quarterly results of Indegene?

For the Sep 2026 quarter, Indegene reported sales of ₹1,124 Cr, up 39.7% year on year and net profit of ₹112 Cr, up 9.9% year on year. The operating margin was 17.1%.

What is the annual revenue of Indegene?

Indegene's sales for the year to Mar 2026 were ₹3,518 Cr; over the last twelve months they were ₹4,138 Cr.

What is the net profit of Indegene?

Net profit for the year to Mar 2026 was ₹400 Cr, and ₹410 Cr over the last twelve months. Earnings per share over the same trailing period were ₹17.12.

How much debt does Indegene have?

Indegene reported borrowings of ₹144 Cr at Mar 2026, against cash and equivalents of ₹382 Cr.

What is the free cash flow of Indegene?

Cash from operations was ₹651 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹605 Cr.

Loading…